Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Select Medical Holdings (SEM) EBIT (2018 - 2026)

Select Medical Holdings (SEM) has disclosed EBIT for 9 consecutive years, with $98.4 million as the latest value for Q1 2026.

  • For Q1 2026, EBIT fell 12.71% year-over-year to $98.4 million; the TTM value through Mar 2026 reached $321.8 million, up 22.56%, while the annual FY2025 figure was $336.2 million, 25.29% up from the prior year.
  • EBIT hit $98.4 million in Q1 2026 for Select Medical Holdings, up from $63.9 million in the prior quarter.
  • Across five years, EBIT topped out at $159.2 million in Q2 2023 and bottomed at -$173.4 million in Q4 2023.
  • Average EBIT over 5 years is $65.6 million, with a median of $91.5 million recorded in 2022.
  • Year-over-year, EBIT crashed 321.39% in 2022 and then skyrocketed 203.14% in 2025.
  • Select Medical Holdings' EBIT stood at -$171.7 million in 2022, then decreased by 1.0% to -$173.4 million in 2023, then skyrocketed by 112.16% to $21.1 million in 2024, then surged by 203.14% to $63.9 million in 2025, then skyrocketed by 53.93% to $98.4 million in 2026.
  • According to Business Quant data, EBIT over the past three periods came in at $98.4 million, $63.9 million, and $73.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.